# Prescreening Study to Identify Potential Wilson Disease Participants for Gene-Editing Clinical Trial

> **NCT07226622** · — · ACTIVE_NOT_RECRUITING · sponsor: **Prime Medicine, Inc.** · enrollment: 30 (estimated)

## Conditions studied

- Wilson Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07226622
- **Lead sponsor:** Prime Medicine, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-12-29
- **Primary completion:** 2027-12
- **Final completion:** 2027-12
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-05-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07226622

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07226622, "Prescreening Study to Identify Potential Wilson Disease Participants for Gene-Editing Clinical Trial". Retrieved via MORVS 2026-10-10 from https://api.morvs.ai/clinical/NCT07226622. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*